HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Curious Britney Spears Positioned As Scent For Daring Women

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Curious Britney Spears will debut in late September backed by a print and TV ad campaign featuring the singer, Elizabeth Arden announced June 10

You may also be interested in...



Spears Does It Again: Singer’s Third Scent To Launch In April

The launch of In Control Curious Britney Spears, a limited-edition fragrance by the singer, will be backed with print ads and an Internet viral campaign, Elizabeth Arden said

Spears Does It Again: Singer’s Third Scent To Launch In April

The launch of In Control Curious Britney Spears, a limited-edition fragrance by the singer, will be backed with print ads and an Internet viral campaign, Elizabeth Arden said

Elizabeth Arden Brings Spears’ Fantasy To Department Stores

Elizabeth Arden is expanding its Britney Spears fragrance franchise in September with the launch of Fantasy Britney Spears, a scent positioned as a sensual and tempting offering, according to the firm

Table

View full table

Tags:
Latest Headlines

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

See All
UsernamePublicRestriction

Register

RS012204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By